{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:27:11Z","timestamp":1760909231305,"version":"3.37.3"},"reference-count":14,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T00:00:00Z","timestamp":1574640000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0225509","type":"journal-article","created":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T16:04:08Z","timestamp":1574697848000},"page":"e0225509","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["A prospective observational study of on-treatment plasma homocysteine levels as a biomarker of toxicity, depression and vitamin supplementation lead-in time pre pemetrexed, in patients with non-small cell lung cancer and malignant mesothelioma"],"prefix":"10.1371","volume":"14","author":[{"given":"Anna","family":"Minchom","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0493-6565","authenticated-orcid":true,"given":"Daisy","family":"Mak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ranga","family":"Gunapala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Walder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajiv","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia","family":"Yousaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Hodgkiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaishree","family":"Bhosle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay","family":"Popat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary E. R.","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2019,11,25]]},"reference":[{"issue":"4","key":"pone.0225509.ref001","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1634\/theoncologist.6-4-363","article-title":"Pemetrexed disodium: a novel antifolate clinically active against multiple solid tumors","volume":"6","author":"AR Hanauske","year":"2001","journal-title":"Oncologist"},{"issue":"14","key":"pone.0225509.ref002","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"NJ Vogelzang","year":"2003","journal-title":"J Clin Oncol"},{"issue":"7135","key":"pone.0225509.ref003","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1136\/bmj.316.7135.894","article-title":"Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. Homocysteine Lowering Trialists' Collaboration","volume":"316","author":"R Clarke","year":"1998","journal-title":"Bmj"},{"issue":"5","key":"pone.0225509.ref004","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/CAD.0000000000000220","article-title":"Plasma homocysteine levels and hematological toxicity in NSCLC patients after the first cycle of pemetrexed under folate supplementation","volume":"26","author":"H Tanaka","year":"2015","journal-title":"Anti-cancer drugs"},{"issue":"1","key":"pone.0225509.ref005","doi-asserted-by":"crossref","first-page":"e000061","DOI":"10.1136\/bmjresp-2014-000061","article-title":"An unblinded, randomised phase II study of platinum-based chemotherapy with vitamin B12 and folic acid supplementation in the treatment of lung cancer with plasma homocysteine blood levels as a biomarker of severe neutropenic toxicity","volume":"1","author":"AR Minchom","year":"2014","journal-title":"BMJ Open Respir Res"},{"issue":"5","key":"pone.0225509.ref006","doi-asserted-by":"crossref","first-page":"363","DOI":"10.7326\/0003-4819-131-5-199909070-00008","article-title":"Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence","volume":"131","author":"JW Eikelboom","year":"1999","journal-title":"Annals of internal medicine"},{"issue":"4","key":"pone.0225509.ref007","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/00043798-199808000-00007","article-title":"Can dietary supplements with folic acid or vitamin B6 reduce cardiovascular risk? Design of clinical trials to test the homocysteine hypothesis of vascular disease","volume":"5","author":"R Clarke","year":"1998","journal-title":"Journal of cardiovascular risk"},{"issue":"5","key":"pone.0225509.ref008","doi-asserted-by":"crossref","first-page":"352","DOI":"10.7326\/0003-4819-131-5-199909070-00006","article-title":"Nonfasting plasma total homocysteine levels and stroke incidence in elderly persons: the Framingham Study","volume":"131","author":"AG Bostom","year":"1999","journal-title":"Annals of internal medicine"},{"issue":"7","key":"pone.0225509.ref009","first-page":"545","article-title":"Homocysteine and methylmalonic acid: markers to predict and avoid toxicity from pemetrexed therapy","volume":"1","author":"C Niyikiza","year":"2002","journal-title":"Molecular cancer therapeutics"},{"issue":"2","key":"pone.0225509.ref010","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1136\/jnnp.69.2.228","article-title":"Homocysteine, folate, methylation, and monoamine metabolism in depression","volume":"69","author":"T Bottiglieri","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"pone.0225509.ref011","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.lungcan.2013.04.008","article-title":"Randomized phase III trial of gemcitabine and cisplatin vs. gemcitabine alone in patients with advanced non-small cell lung cancer and a performance status of 2: the CAPPA-2 study","volume":"81","author":"A Morabito","year":"2013","journal-title":"Lung Cancer"},{"issue":"11","key":"pone.0225509.ref012","doi-asserted-by":"crossref","first-page":"S1807","DOI":"10.1016\/j.jtho.2017.09.461","article-title":"MA 03.02 Timing of B12\/Folate Supplementation in NSCLC Patients on Pemetrexed Based Chemotherapy: Final Results of the PEMVITASTART Randomized Trial","volume":"12","author":"N Singh","year":"2017","journal-title":"Journal of Thoracic Oncology"},{"issue":"11","key":"pone.0225509.ref013","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1634\/theoncologist.2014-0221","article-title":"A prospective study of shortened vitamin supplementation prior to cisplatin-pemetrexed therapy for non-small cell lung cancer","volume":"19","author":"Y Takagi","year":"2014","journal-title":"Oncologist"},{"issue":"6","key":"pone.0225509.ref014","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.cllc.2018.05.017","article-title":"Safety of Same-Day Vitamin B12 Supplementation in Patients Receiving Pemetrexed for the Treatment of Non-Small-Cell Lung Cancer or Pleural Mesothelioma: A Retrospective Analysis","volume":"19","author":"Z Schlei","year":"2018","journal-title":"Clin Lung Cancer"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0225509","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T16:04:21Z","timestamp":1574697861000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0225509"}},"subtitle":[],"editor":[{"given":"Albiruni","family":"Abdul Razak","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2019,11,25]]},"references-count":14,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2019,11,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0225509","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2019,11,25]]}}}